Health

The FDA has officially removed Semaglutide, Novo Nordisk’s Wegovy, and Ozempic from the drug shortage list, offering relief to countless individuals dependent on these medications for diabetes and weight management. This milestone marks a turning point for people like Jake, a father who struggled to access his prescription amid the scarcity. As supply stabilizes, patients can now regain control of their health without the stress of searching for alternatives. Read on to learn how this decision impacts those affected and what lies ahead for the future of medication accessibility.

Autism Spectrum Disorder (ASD) is a complex condition that influences how a person communicates, interacts, and experiences the world. While every individual with autism is unique, many wonder: What is the reason of autism? The answer isn’t straightforward....

  Autism is Not a Disability, It’s a Different Ability Autism, or Autism Spectrum Disorder (ASD), is not an illness or a disease—it is simply a different way of experiencing the world. People with autism process information, emotions, and social interactions in a...